Translational Research in Oncology   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Edmonton Canada (1997)

Organization Overview

First Clinical Trial
2009
NCT00719212
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Translational Research in Oncology | Translational Research in Oncology-U.S

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Carcinoma (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 2)

Carcinoma, Small Cell (Phase 2)

Glioblastoma (Phase 2)

Hypersensitivity (Phase 2)

Lung Neoplasms (Phase 2)

Ovarian Neoplasms (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 21
  • # of Trial APIs: 25